Published in the Journal of the American Heart Association, the study showcases the potential of AI-powered heart sound analysis to transform early detection and management of pulmonary hypertension.
The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback